Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07072312 · ClinicalTrials.gov registry record · NA
Feasibility, Acceptability and Fidelity of Integrating a Navigation Intervention Into Tobacco Treatment Program
A NA study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT07072312 is a NA study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 93 participants.
The verdict
NCT07072312, a NA study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
Patient Navigation is being included as part of a tobacco treatment program for cancer patients to help patients overcome barriers to quitting.
Interventions
- BEHAVIORAL Adjuvant Patient Navigation for Tobacco Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2022-11-10 |
| Est. Completion | 2024-08-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07072312
The ClinicalTrials.gov registry entry for NCT07072312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adjuvant Patient Navigation for Tobacco Treatment is the first listed.
NCT07072312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07072312 about?
NCT07072312 is a clinical study titled "Feasibility, Acceptability and Fidelity of Integrating a Navigation Intervention Into Tobacco Treatment Program". Patient Navigation is being included as part of a tobacco treatment program for cancer patients to help patients overcome barriers to quitting.
What is the current status of trial NCT07072312?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2022-11-10. Estimated completion is 2024-08-27.
What interventions are being tested in trial NCT07072312?
The interventions under investigation include: Adjuvant Patient Navigation for Tobacco Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT07072312?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.